Groves AM - Search Results

1

The role of positron emission tomography in the management of pancreatic cancer.

Pakzad F, Groves AM, Ell PJ. Pakzad F, et al. Among authors: groves am. Semin Nucl Med. 2006 Jul;36(3):248-56. doi: 10.1053/j.semnuclmed.2006.03.005. Semin Nucl Med. 2006. PMID: 16762614 Review.

2

Discordant uptake of F-18 FDG and In-111 WBC in systemic vasculitis.

Balan K, Voutnis D, Groves A. Balan K, et al. Clin Nucl Med. 2003 Jun;28(6):485-6. doi: 10.1097/01.RLU.0000067509.25288.62. Clin Nucl Med. 2003. PMID: 12917530 No abstract available.

3

Positron emission tomography with FDG to show thymic carcinoid.

Groves AM, Mohan HK, Wegner EA, Hain SF, Bingham JB, Clarke SE. Groves AM, et al. AJR Am J Roentgenol. 2004 Feb;182(2):511-3. doi: 10.2214/ajr.182.2.1820511. AJR Am J Roentgenol. 2004. PMID: 14736691 No abstract available.

4

Myocardial perfusion scintigraphy: patients' perception of benefit and risk.

Groves AM, Kayani I, Syed R, Gacinovic S, Nagabushan N, Ell PJ. Groves AM, et al. Nucl Med Commun. 2004 Dec;25(12):1219-22. doi: 10.1097/00006231-200412000-00011. Nucl Med Commun. 2004. PMID: 15640782

5

Combined F-18 FDG positron emission tomography/computed tomography in the diagnosis of colonic polyps: the potential and limitations of the technique.

Kayani I, Groves AM, Syed R, Bomanji J. Kayani I, et al. Among authors: groves am. Clin Nucl Med. 2005 Feb;30(2):116-7. doi: 10.1097/00003072-200502000-00013. Clin Nucl Med. 2005. PMID: 15647682 No abstract available.

6

How often do patients undergo repeat PET or PET/CT examinations? Experience from a UK institution.

Groves AM, Cullum I, Syed R, Nagabushan N, Kayani I, Pakzad F, Ell PJ. Groves AM, et al. Nucl Med Commun. 2005 Feb;26(2):137-9. doi: 10.1097/00006231-200502000-00010. Nucl Med Commun. 2005. PMID: 15657507

7

Imaging bronchial carcinoma in situ: possible roles for combined positron emission tomography (PET)-CT.

Kayani I, Groves AM, Ell PJ, George PJ, Bomanji J. Kayani I, et al. Among authors: groves am. Lancet Oncol. 2005 Mar;6(3):190. doi: 10.1016/S1470-2045(05)01772-9. Lancet Oncol. 2005. PMID: 15737837 No abstract available.

8

Impact of combined (18)F-FDG PET/CT in head and neck tumours.

Syed R, Bomanji JB, Nagabhushan N, Hughes S, Kayani I, Groves A, Gacinovic S, Hydes N, Visvikis D, Copland C, Ell PJ. Syed R, et al. Br J Cancer. 2005 Mar 28;92(6):1046-50. doi: 10.1038/sj.bjc.6602464. Br J Cancer. 2005. PMID: 15770212 Free PMC article.

9

The absent kidney in 99Tcm-MAG3 renogram: a dramatic reversible consequence of contrast nephrotoxicity superimposed on renal obstruction.

Kayani I, Groves AM, Syed R, Nagabushan N, Pakzad F, Prvulovich EM, Bomanji JB. Kayani I, et al. Among authors: groves am. Br J Radiol. 2005 Apr;78(928):349-52. doi: 10.1259/bjr/30076658. Br J Radiol. 2005. PMID: 15774598

10

Oral contrast medium in PET/CT: should you or shouldn't you?

Groves AM, Kayani I, Dickson JC, Townsend C, Croasdale I, Syed R, Nagabushan N, Hain SF, Ell PJ, Bomanji JB. Groves AM, et al. Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1160-6. doi: 10.1007/s00259-005-1833-9. Epub 2005 Jun 4. Eur J Nucl Med Mol Imaging. 2005. PMID: 15937685 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page